Live Update From the Liveblog of
Thursday, February 11, 2021
Common asthma drug can reduce COVID hospitalizations by 90% — study
A common asthma drug can dramatically reduce hospitalizations, symptoms and recovery time among COVID-19 if taken up to a week after the appearance of symptoms, Oxford University researchers have said according to various reports.
Inhaling the steroid budesonide “reduced the risk of urgent care or hospitalization by 90% when compared with usual care,” the Reuters news agency reports, citing the Oxford experts.
The results were reached after a 28-day study of 146 patients.
“I am heartened that a relatively safe, widely available and well-studied medicine… could have an impact on the pressures we are experiencing during the pandemic,” says researcher Mona Bafadhel, according to Reuters.